GTC Biotherapeutics (fka GTCB)

[Spice is nice]

The first rule in biotech is don't get scammed.

One way to adhere to that rule is by discounting language such as "we expect", "we are preparing for", "next quarter", and last but not least, "we project", in company statements.

And not to pick on GTC because I have not picked up any obfuscation on their part, but they also projected substantially less burn this year, and, per your conversation with them, also projected they had no need for additional financing 2 months ago.

When I look at a filing, or statement in this case, I look at numbers, dates and other specifics. I leave the fluff to others.